4′-C-Cholesterol/Pyridyl-2′-O-Methyl Uridine-Functionalized siRNA Enhances Stability and Carrier-Free Gene Silencing
- 5 June 2025
- journal article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 36 (6) , 1234-1246
Abstract
Chemical modifications and targeted delivery through the conjugation of small molecules have transformed the potential of siRNA-based therapeutics. These advancements address key challenges, such as poor cellular uptake, low bioavailability, and limited metabolic stability, making siRNA delivery more efficient and clinically viable. Cholesterol-conjugated siRNA enables cellular uptake through lipoprotein pathways without transfection agents. In this study, we reported the synthesis of 4'-C-cholesterol-2'-O-methyl (4'-C-chol-2'-OMe) and 4'-C-methylpyridine-2'-O-methyl (4'-C-Mpy-2'-OMe) uridine conjugates via copper(I)-catalyzed azide-alkyne cycloaddition (CuAAC) and their incorporation at the 3'-overhangs of the siRNA duplex. A single incorporation of 4'-C-chol-2'-OMe or 4'-C-Mpy-2'-OMe uridine marginally increased the stability of the siRNA duplex. In the nuclease resistance assay, 4'-C-Mpy-2'-OMe modification at the penultimate position of the 3'-end of poly dT20 showed significant resistance against snake venom phosphodiesterase (SVPD), 3'-specific exonucleases. Gene silencing activity using anti-Renilla siRNA exhibited enhanced gene silencing activity when a single modification was incorporated at the 3'-overhang of the passenger strand. Similarly, 4'-C-Mpy-2'-OMe modification at the 3'-overhang of the passenger strand in anti-Bcl-2 siRNA showed compatibility to RISC assembly and exhibited effective gene silencing against the endogenous Bcl-2 gene. A molecular modeling study illustrated that the 4'-C-Mpy-2'-OMe uridine at the 3'-overhang of the guide strand shows minimal interaction with the PAZ domain of the hAgo2 protein. The dual incorporation of cholesterol modifications at the 3'-overhang of both strands resulted in 68% and 93% reductions in Renilla luciferase expression at 1000 nM concentration after 48 and 96 h, respectively, in a carrier-free system. This study demonstrated that C4'-cholesterol conjugation provides effective cellular uptake, high nuclease resistance, and prolonged silencing activity in carrier-free mode.Keywords
Funding Information
- Council of Scientific and Industrial Research, India
- Anusandhan National Research Foundation (CRG/2022/003222)
- Indian Institute of Technology Kharagpur
- Indian Institute of Technology Bombay
This publication has 52 references indexed in Scilit:
- Influence of Sugar Modifications on the Nucleoside Conformation and Oligonucleotide Stability: A Critical ReviewThe Chemical Record, 2022
- Therapeutic siRNA: State-of-the-Art and Future PerspectivesBioDrugs, 2022
- Role of siRNA-based nanocarriers for the treatment of neurodegenerative diseasesDrug Discovery Today, 2022
- An albumin-mediated cholesterol design-based strategy for tuning siRNA pharmacokinetics and gene silencingJournal of Controlled Release, 2016
- The Structure of Human Argonaute-2 in Complex with miR-20aCell, 2012
- DNA‐Based Carbohydrate Biochips: A Platform for Surface Glyco‐EngineeringAngewandte Chemie, 2007
- Toxicogenomics of non-viral drug delivery systems for RNAi: Potential impact on siRNA-mediated gene silencing activity and specificityAdvanced Drug Delivery Reviews, 2007
- Steroid and lipid conjugates of siRNAs to enhance cellular uptake and gene silencing in liver cellsBioorganic & Medicinal Chemistry Letters, 2004
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- Structural principles for the inhibition of the 3′-5′ exonuclease activity of Escherichia coli DNA polymerase I by phosphorothioatesJournal of Molecular Biology, 1998